QQ客服 官方微博 反馈留言

	S-1 and Cisplatin versus Docetaxel and Cisplatin in Patients with Untreated Advanced NSCLC: An Randomised, Multicenter, Phase 3 Trial
	Shi, Yuankai; Wang, Mengzhao; He, Jianxing; Chang, Jianhua; Han, Baohui; Liu, Xiaoqing; Chen, Gongyan; Zhou, Caicun; Liu, Jiwei; Pan, Hongming
	2015
卷号	10期号:9页码:S174-S174
关键词	S-1 phase 3 trial Therapy NSCLC
ISSN号	1556-0864
URL标识	查看原文
收录类别	SCIE
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6663243
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Shi, Yuankai,Wang, Mengzhao,He, Jianxing,et al. S-1 and Cisplatin versus Docetaxel and Cisplatin in Patients with Untreated Advanced NSCLC: An Randomised, Multicenter, Phase 3 Trial[J],2015,10(9):S174-S174.
APA	Shi, Yuankai.,Wang, Mengzhao.,He, Jianxing.,Chang, Jianhua.,Han, Baohui.,...&Xu, Nong.(2015).S-1 and Cisplatin versus Docetaxel and Cisplatin in Patients with Untreated Advanced NSCLC: An Randomised, Multicenter, Phase 3 Trial.,10(9),S174-S174.
MLA	Shi, Yuankai,et al."S-1 and Cisplatin versus Docetaxel and Cisplatin in Patients with Untreated Advanced NSCLC: An Randomised, Multicenter, Phase 3 Trial".10.9(2015):S174-S174.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。